Trials / Conditions / Primary Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

12 registered clinical trials studyying Primary Axillary Hyperhidrosis.

Status	Trial	Sponsor	Phase
Completed	Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Pri NCT05863104	Dr. August Wolff GmbH & Co. KG Arzneimittel	Phase 2
Completed	Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating NCT04599907	Candesant Biomedical, Inc.	N/A
Withdrawn	Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Un NCT04159610	Dr. August Wolff GmbH & Co. KG Arzneimittel	Phase 2
Completed	A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis NCT03785587	Botanix Pharmaceuticals	Phase 2
Completed	Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients Wit NCT03658616	Dr. August Wolff GmbH & Co. KG Arzneimittel	Phase 3
Completed	A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis NCT03627468	Botanix Pharmaceuticals	Phase 3
Completed	Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects NCT03037788	Dr. August Wolff GmbH & Co. KG Arzneimittel	Phase 1
Completed	Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis NCT03054480	Mae Fah Luang University Hospital	N/A
Completed	Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis NCT02823340	Xijing Hospital	N/A
Completed	Ulthera® System for Treating Axillary Hyperhidrosis NCT02286765	Ulthera, Inc	N/A
Completed	Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis NCT01799824	Anterios Inc.	Phase 2
Terminated	A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis NCT01722461	Ulthera, Inc	N/A